262 related articles for article (PubMed ID: 12931279)
1. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers.
Brem H; Young J; Tomic-Canic M; Isaacs C; Ehrlich HP
Surg Technol Int; 2003; 11():23-31. PubMed ID: 12931279
[TBL] [Abstract][Full Text] [Related]
2. Healing of elderly patients with diabetic foot ulcers, venous stasis ulcers, and pressure ulcers.
Brem H; Tomic-Canic M; Tarnovskaya A; Ehrlich HP; Baskin-Bey E; Gill K; Carasa M; Weinberger S; Entero H; Vladeck B
Surg Technol Int; 2003; 11():161-7. PubMed ID: 12931298
[TBL] [Abstract][Full Text] [Related]
3. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.
Brem H; Balledux J; Bloom T; Kerstein MD; Hollier L
Arch Surg; 2000 Jun; 135(6):627-34. PubMed ID: 10843357
[TBL] [Abstract][Full Text] [Related]
4. Pinch graft harvesting technique for surgical closure of the diabetic foot.
Ramanujam CL; Zgonis T
Clin Podiatr Med Surg; 2012 Oct; 29(4):585-8. PubMed ID: 23044064
[TBL] [Abstract][Full Text] [Related]
5. Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers.
Saap LJ; Donohue K; Falanga V
Dermatol Surg; 2004 Aug; 30(8):1095-100. PubMed ID: 15274699
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of fresh fibroblast allografts in the treatment of diabetic foot ulcers.
Han SK; Kim HS; Kim WK
Dermatol Surg; 2009 Sep; 35(9):1342-8. PubMed ID: 19500128
[TBL] [Abstract][Full Text] [Related]
7. Wound-healing protocols for diabetic foot and pressure ulcers.
Brem H; Jacobs T; Vileikyte L; Weinberger S; Gibber M; Gill K; Tarnovskaya A; Entero H; Boulton AJ
Surg Technol Int; 2003; 11():85-92. PubMed ID: 12931288
[TBL] [Abstract][Full Text] [Related]
8. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
Curran MP; Plosker GL
BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
[TBL] [Abstract][Full Text] [Related]
9. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group.
Falanga V; Margolis D; Alvarez O; Auletta M; Maggiacomo F; Altman M; Jensen J; Sabolinski M; Hardin-Young J
Arch Dermatol; 1998 Mar; 134(3):293-300. PubMed ID: 9521027
[TBL] [Abstract][Full Text] [Related]
10. Dermagraft in the treatment of diabetic foot ulcers.
Bowering CK
J Cutan Med Surg; 1998 Dec; 3 Suppl 1():S1-29-32. PubMed ID: 10082605
[No Abstract] [Full Text] [Related]
11. Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: a pilot study.
Han SK; Choi KJ; Kim WK
Plast Reconstr Surg; 2004 Dec; 114(7):1783-9. PubMed ID: 15577349
[TBL] [Abstract][Full Text] [Related]
12. Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes--a pilot study.
You HJ; Han SK; Lee JW; Chang H
Wound Repair Regen; 2012; 20(4):491-9. PubMed ID: 22672334
[TBL] [Abstract][Full Text] [Related]
13. Influence of human fibroblasts on development and quality of multilayered composite grafts in athymic nude mice.
Cedidi CC; Wilkens L; Berger A; Ingianni G
Eur J Med Res; 2007 Nov; 12(11):541-55. PubMed ID: 18024263
[TBL] [Abstract][Full Text] [Related]
14. Utilization of living bilayered cell therapy (Apligraf) for heel ulcers.
Karr J
Adv Skin Wound Care; 2008 Jun; 21(6):270-4. PubMed ID: 18525250
[TBL] [Abstract][Full Text] [Related]
15. An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports.
Hasegawa T; Suga Y; Mizoguchi M; Muramatsu S; Mizuno Y; Ogawa H; Kubo K; Kuroyanagi Y
J Dermatol; 2005 Sep; 32(9):715-20. PubMed ID: 16361714
[TBL] [Abstract][Full Text] [Related]
16. The longevity of a bilayered skin substitute after application to venous ulcers.
Phillips TJ; Manzoor J; Rojas A; Isaacs C; Carson P; Sabolinski M; Young J; Falanga V
Arch Dermatol; 2002 Aug; 138(8):1079-81. PubMed ID: 12164746
[TBL] [Abstract][Full Text] [Related]
17. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft.
Browne AC; Vearncombe M; Sibbald RG
Ostomy Wound Manage; 2001 Oct; 47(10):44-9. PubMed ID: 11890078
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic Skin Substitutes Versus Human Placental Membrane Products in the Management of Diabetic Foot Ulcers: A Narrative Comparative Evaluation of the Literature.
Luck J; Rodi T; Geierlehner A; Mosahebi A
Int J Low Extrem Wounds; 2019 Mar; 18(1):10-22. PubMed ID: 30663450
[TBL] [Abstract][Full Text] [Related]
19. Clinical application of a tissue-cultured skin autograft: an alternative for the treatment of non-healing or slowly healing wounds?
Zöller N; Valesky E; Butting M; Hofmann M; Kippenberger S; Bereiter-Hahn J; Bernd A; Kaufmann R
Dermatology; 2014; 229(3):190-8. PubMed ID: 25227494
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study.
Hu S; Kirsner RS; Falanga V; Phillips T; Eaglstein WH
Wound Repair Regen; 2006; 14(4):427-33. PubMed ID: 16939570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
